A Biomarker for Cognitive Fatigue Using Functional Imaging in MS
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The purpose of this research study is to investigate the effectiveness of MS Disease modifying medications on cognitive fatigue in persons with relapsing remitting multiple sclerosis (RRMS). Cognitive fatigue is the kind of fatigue that occurs after intense mental concentration as after a session of problem solving.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 64
Healthy Volunteers: t
View:
• Age between 18-64.
• Relapsing remitting multiple sclerosis
• Been newly prescribed a new disease modifying medication for MS (either Ocrevus or Copaxone)
• or healthy volunteer who can speak English fluently.
Locations
United States
New Jersey
Kessler Foundation
RECRUITING
West Orange
Contact Information
Primary
Nancy Moore, M.A.
nbmoore@kesslerfoundation.org
973-324-8450
Backup
Angela Smith, M.A.
asmith@kesslerfoundation.org
973-324-8448
Time Frame
Start Date: 2021-05-06
Estimated Completion Date: 2024-12
Participants
Target number of participants: 60
Treatments
Multiple Sclerosis group 1
Individuals with Multiple Sclerosis who are going to be starting Ocrevus as determined by Neurologist as part of clinical care.
Multiple Sclerosis group 2
Individuals with Multiple Sclerosis who are going to be starting Copaxone as determined by Neurologist as part of clinical care.
Healthy Controls
Healthy individuals who are age, gender and education matched to the other groups.
Related Therapeutic Areas
Sponsors
Leads: Kessler Foundation
Collaborators: Hackensack Meridian Health